Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestineAlex Sparreboom, Olaf van Tellingen, Judith van Asperen et al.|Proceedings of the National Academy of Sciences|1997Cited by 884
Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvementSjoerd Rodenhuis, Emiel J. Rutgers, Dick J. Richel et al.|The Lancet|1998Cited by 243
Preclinical pharmacokinetics of paclitaxel and docetaxelAlex Sparreboom, Jos H. Beijnen, Willem J. Nooijen et al.|Anti-Cancer Drugs|1998Cited by 148
Tissue distribution, metabolism and excretion of paclitaxel in miceAlex Sparreboom, Jos H. Beijnen, Olaf van Tellingen et al.|Anti-Cancer Drugs|1996Cited by 129
Isolation, purification, and biological activity of mono- and dihydroxylated paclitaxel metabolites from human fecesAlexander Sparreboom, Jos H. Beijnen, Manon Huizing et al.|Cancer Chemotherapy and Pharmacology|1995Cited by 66